N

NewAmsterdam Pharma

14 employees

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Pharmaceutical

Life Science

Date founded

2019

Funding rounds raised

Total raised

$235M

from 14 investors over 14 rounds

N

NewAmsterdam Pharma raised $235M on November 23, 2022

Investors: Life Sciences Partners (LSP), Forbion, Frazier Healthcare Partners, Medicxi, RA Capital Management, L.P. and GMT Capital

N

NewAmsterdam Pharma raised $194M on January 14, 2021

Investors: Forbion, GL Capital Group, Morningside Venture Capital 晨兴资本, JVC Investment Partners, Medpace, Presight Capital and LSP (Life Sciences Partners)

N

NewAmsterdam Pharma raised undisclosed on January 1, 2019

Investors: BGV (BioGeneration Ventures)